PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 62 filers reported holding PRELUDE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $9,703 | -34.6% | 3,140 | -4.8% | 0.00% | – |
Q2 2023 | $14,837 | -86.0% | 3,297 | -78.5% | 0.00% | – |
Q1 2022 | $106,000 | -48.3% | 15,316 | -7.0% | 0.00% | – |
Q4 2021 | $205,000 | -51.5% | 16,470 | +21.8% | 0.00% | -100.0% |
Q3 2021 | $423,000 | -1.2% | 13,524 | -9.5% | 0.00% | 0.0% |
Q2 2021 | $428,000 | -34.0% | 14,939 | -0.1% | 0.00% | 0.0% |
Q1 2021 | $648,000 | -34.8% | 14,947 | +7.6% | 0.00% | 0.0% |
Q4 2020 | $994,000 | – | 13,888 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Orbimed Advisors | 10,039,691 | $287,436,000 | 2.91% |
Baker Brothers Advisors | 10,123,824 | $289,845,000 | 1.27% |
Logos Global Management LP | 400,000 | $11,452,000 | 0.96% |
Rock Springs Capital Management LP | 382,359 | $10,947,000 | 0.22% |
HHLR ADVISORS, LTD. | 583,333 | $16,701,000 | 0.17% |
Virtus ETF Advisers LLC | 6,622 | $190,000 | 0.08% |
Jump Financial, LLC | 13,700 | $392,000 | 0.04% |
ARS Investment Partners, LLC | 7,400 | $212,000 | 0.02% |
FEDERATED HERMES, INC. | 336,100 | $9,623,000 | 0.02% |
UBS ASSET MANAGEMENT AMERICAS LLC | 1,287,735 | $36,867,853,000 | 0.02% |